000 01260 a2200397 4500
005 20250511193001.0
264 0 _c19920611
008 199206s 0 0 eng d
022 _a0031-6970
024 7 _a10.1007/BF00266364
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWanwimolruk, S
245 0 0 _aPolymorphism of debrisoquine oxidation in New Zealand Caucasians.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_c1992
300 _a349-50 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aDebrisoquin
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNew Zealand
650 0 4 _aOxidation-Reduction
650 0 4 _aPhenotype
650 0 4 _aPolymorphism, Genetic
650 0 4 _aWhite People
700 1 _aDenton, J R
700 1 _aFerry, D G
700 1 _aBeasley, M
700 1 _aBroughton, J R
773 0 _tEuropean journal of clinical pharmacology
_gvol. 42
_gno. 3
_gp. 349-50
856 4 0 _uhttps://doi.org/10.1007/BF00266364
_zAvailable from publisher's website
999 _c1583540
_d1583540